About Argenx
Argenx is a clinical-stage biotechnology company developing a pipeline of differentiated antibody-based therapies for autoimmune diseases and cancer.
Sector
Biotech
Headquarters
Ghent, Belgium
Founded
2008
Employees
1,100
In the News
AUTO-PULLEDNo coverage yet — our newsroom tracks Argenx continuously.